Neuroscience
Adverse Effect
8%
Alzheimer's Disease
10%
AMPA
5%
Antidepressant
23%
Bipolar Depression
10%
Brain Network
7%
Cognitive Disorders
18%
Cognitive Effect
15%
Cognitive Function
13%
Depression
12%
Electrical Brain Stimulation
9%
Electroconvulsive Therapy
100%
Executive Functions
8%
Fragile X Syndrome
7%
Functional near Infrared Spectroscopy
6%
Hamilton Rating Scale for Depression
6%
Ictal
8%
Late Life Depression
10%
Major Depressive Disorder
59%
Meta-Analysis
9%
Neuromodulation
11%
Neuroplasticity
6%
Prefrontal Cortex
7%
Randomized Controlled Trial
10%
Synapse
5%
Transcranial Direct Current Stimulation
8%
Transcranial Magnetic Stimulation
37%
Treatment-Resistant Depression
20%
Venlafaxine
6%
Keyphrases
Alzheimer's Disease
5%
Antidepressants
5%
Clinical Outcomes
6%
Cognitive Effects
11%
Cognitive Impairment
6%
Cognitive Screening
5%
Depression Severity
5%
Electroconvulsive Therapy
35%
Late-life Depression
7%
Magnetic Seizure Therapy
13%
Major Depressive Disorder
23%
Neurocognitive Effects
9%
Neurocognitive Function
9%
Pharmacotherapy
5%
Remission
11%
Repetitive Transcranial Magnetic Stimulation (rTMS)
10%
Right Unilateral
5%
Transcranial Direct-current Stimulation (tDCS)
5%
Treatment-resistant Depression
7%
Ultrabrief Pulse
6%
Medicine and Dentistry
Antidepressant
5%
Cognitive Defect
5%
Drug Therapy
9%
Electroconvulsive Therapy
44%
Epileptic Seizure
15%
Major Depressive Episode
31%
Pulse Rate
7%
Randomized Clinical Trial
5%
Repetitive Transcranial Magnetic Stimulation
9%
Treatment of Depression
7%
Treatment Resistant Depression
7%